Skip to main content

Electromed, Inc.

corporate_fare Company Profile

Electromed, Inc.

ELMD·NYSE·Industrial Applications And Services·CIK 0001488917

Electromed, Inc. develops, manufactures, markets and sells innovative products that provide airway clearance therapy, including the SmartVest® Airway Clearance System ("SmartVest System"), to patients with compromised pulmonary function. The SmartVest System generates High Frequency Chest Wall Oscillation ("HFCWO"), an airway clearance therapy. It features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide therapy to clear the lung and airway from retained secretions and mucus which can harbor bacteria and lead to infection. Impaired airway clearance, when mucus cannot be expectorated, may result in labored breathing, inflammatory response and/or immune systems boosting mucus production that invites bacteria trapped in stagnant secretions to cause infections. Studies show that HFCWO therapy is as effective an airway clearance method for patients who have compromised pulmonary function as traditional chest physical therapy ("CPT") administered by a respiratory therapist. Electromed primarily employs a direct-to-patient and provider model, through which it obtains patient referrals from clinicians, manages insurance claims on behalf of its patients, and delivers the SmartVest System to patients, training them on proper use in their homes. This model allows Electromed to directly approach patients and clinicians, whereby it disintermediates the traditional home medical equipment ("HME") channel and captures both the manufacturer and distributor margins. Electromed also sells its products in the acute care setting for patients in a post-surgical or intensive care unit, or who were admitted for a lung infection brought on by compromised airway clearance. Electromed was incorporated in Minnesota in 1992. Its common stock is listed on the NYSE American under the ticker symbol "ELMD."

Electromed, Inc. (NYSE:ELMD) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 1 item for ELMD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-10, rated 7/10. Recent SEC coverage for ELMD spans 8-K.

Recent high-impact activity:

  • Electromed Posts 16th Straight Growth Quarter: Revenue +10.6%, EPS $0.32

Financial Snapshot

Fiscal year ended June 30, 2026
Revenue
$73.78M
Net Income
$11.3M
Diluted EPS
$1.30
Op. Cash Flow
$9.66M
Free Cash Flow
$8.41M
Gross Profit
$57.94M
Operating Income
$13.88M
Cash & Equivalents
$20.45M
Debt / Equity
0.00×
Net Margin
15.3%
Shares Outstanding
8.37M sh
Source: 10-K · filed 2026-08-25 · accession 0001437749-26-028914

Short Interest & Short Volume

4.77 days to cover

FINRA reported short interest of 180,632 shares in ELMD as of the October 30, 2026 settlement, a 7.0% decrease from the prior period — about 4.8 days to cover at its recent average daily volume. On November 19, 2026, 41.0% of ELMD volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)180,632 shares as of October 30, 2026
Change vs prior period▼ 7.0%
Days to cover4.77 at avg daily volume of 37,838
Daily short volume (FINRA facilities)41.0% of 23,794 shares on November 19, 2026
5-day average short volume51.7%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

$22.98
52-week range · as of 2026-11-10 $22.98 – $47.4
Market cap
$187.84M
Volume
80.8K (1.5× avg)
3-mo avg 53.9K
Live data · 2026-11-20 22:18 UTC · After hours

show_chartPrice Chart

Loading chart...

feed ELMD - Latest Insights

ELMD
Nov 10, 2026, 4:07 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $27.18
Real-time Price: $22.98 info
Change: -$4.20 (-15%) info
Market Cap: $187.839M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets